-
1
-
-
85153548207
-
-
Available: http://www.fda/gov/Safety/MedWatch/SafetyInformation/ ucm203615.htm.
-
-
-
-
2
-
-
77954527197
-
Milnacipran: A new treatment for fibromyalgia syndrome
-
K.S. Hale,. Milnacipran: a new treatment for fibromyalgia syndrome. J. Pharm. Technol. 2010, 26, 129.
-
(2010)
J. Pharm. Technol.
, vol.26
, pp. 129
-
-
Hale, K.S.1
-
3
-
-
77953869271
-
Determination of milnacipran in human plasma using GC-MS
-
E. Ucakturk, C. Safak,. Determination of milnacipran in human plasma using GC-MS. Chromatographia 2010, 72, 111.
-
(2010)
Chromatographia
, vol.72
, pp. 111
-
-
Ucakturk, E.1
Safak, C.2
-
4
-
-
77953332985
-
Development and validation of RP-HPLC method for determination of milnacipran hydrochloride in pharmaceutical formulations
-
P. Mehta, J. D. M. Khatri,. Development and validation of RP-HPLC method for determination of milnacipran hydrochloride in pharmaceutical formulations. Int. J. Pharm. Pharmaceut. Sci. 2010, 2, 137.
-
(2010)
Int. J. Pharm. Pharmaceut. Sci.
, vol.2
, pp. 137
-
-
Mehta, P.1
Khatri, J.D.M.2
-
5
-
-
2542426446
-
Determination of milnacipran, a serotonin and noradrenaline reuptake inhibitor, in human plasma using liquid chromatography with spectrofluorimetric detection
-
C. Puozzo, C. Filaquier, G. Zorza,. Determination of milnacipran, a serotonin and noradrenaline reuptake inhibitor, in human plasma using liquid chromatography with spectrofluorimetric detection. J. Chromatogr. B 2004, 806, 221.
-
(2004)
J. Chromatogr. B
, vol.806
, pp. 221
-
-
Puozzo, C.1
Filaquier, C.2
Zorza, G.3
-
6
-
-
38549117445
-
Chiral HPLC analysis of milnacipran and its FMOC-derivative on cellulose-based stationary phases
-
A. Patti, S. Pedotti, C. Sanfilippo,. Chiral HPLC analysis of milnacipran and its FMOC-derivative on cellulose-based stationary phases. Chirality 2008, 20, 63.
-
(2008)
Chirality
, vol.20
, pp. 63
-
-
Patti, A.1
Pedotti, S.2
Sanfilippo, C.3
-
7
-
-
80052703234
-
Comparative validation study to assay milnacipran hydrochloride in capsules by a stability-indicating LC and a second order derivative UV spectroscopic method
-
C. L. Dias, L. Bajerski, R. C. Rossi, A. M. Bergold, P. E. Fröehlich,. Comparative validation study to assay milnacipran hydrochloride in capsules by a stability-indicating LC and a second order derivative UV spectroscopic method. Pharmaceut. Anal. Acta 2010, 1, 1.
-
(2010)
Pharmaceut. Anal. Acta
, vol.1
, pp. 1
-
-
Dias, C.L.1
Bajerski, L.2
Rossi, R.C.3
Bergold, A.M.4
Fröehlich, P.E.5
-
8
-
-
84875548262
-
A stability indicating U-HPLC method for milnacipran in bulk drugs and pharmaceutical dosage forms
-
N. Tondepu, S. S. Sait, K. V. Surendranath, R. K. Kaja, S. Kumar,. A stability indicating U-HPLC method for milnacipran in bulk drugs and pharmaceutical dosage forms. Am. J. Anal. Chem. 2012, 3, 40.
-
(2012)
Am. J. Anal. Chem.
, vol.3
, pp. 40
-
-
Tondepu, N.1
Sait, S.S.2
Surendranath, K.V.3
Kaja, R.K.4
Kumar, S.5
-
10
-
-
85153540906
-
Stability testing of new drug substances and products, ICH guideline, Q1A (R2)
-
Food and Drug Administration, USA, February
-
Stability testing of new drug substances and products, ICH guideline, Q1A (R2). International Conference on Harmonization, Food and Drug Administration, USA, February, 2003.
-
(2003)
International Conference on Harmonization
-
-
-
11
-
-
85153543878
-
Photostability testing on new drug substances and products, ICH guideline, Q1B
-
Food and Drug Administration, USA
-
Photostability testing on new drug substances and products, ICH guideline, Q1B. International Conference on Harmonization, Food and Drug Administration, USA, 1996.
-
(1996)
International Conference on Harmonization
-
-
-
12
-
-
55449119909
-
Validation of analytical procedures: Text and methodology, ICH guideline, Q2 (R1)
-
Food and Drug Administration, USA, November
-
Validation of analytical procedures: text and methodology, ICH guideline, Q2 (R1). International Conference on Harmonization, Food and Drug Administration, USA, November, 2005.
-
(2005)
International Conference on Harmonization
-
-
|